The event aims to encourage female students to continue studying STEM subjects at college and university. Holly spoke about her career to date and what being a #TrialStatistician involves.

The successful candidate will be responsible for:

• Day to day management of the trial(s);
• Liaising with stakeholders and participating centres to ensure successful recruitment and delivery;
• Co-ordination of data management and biological sample collection activities.

Find out more about our sustainability work here:
www.icr.ac.uk/research-and...

One of our trial managers presented on our experience of a recent routine MHRA inspection. A clinical trials programme manager presented as part of the real world experiences of eTMF systems session. And finally our sustainability project manager presented about greener trials.

INTERACT is exploring who took part in recent cancer clinical trials to find out whether anyone was less likely to be included.

Results will help us develop dedicated support for any groups who have been left out in the past. Find out more about the project here: www.icr.ac.uk/interact

Results showed that, for patients with head and neck cancer, there was no evidence of a difference in rates of key toxicities between standard intensity-modulated radiotherapy (IMRT) and proton beam therapy (PBT).

Ragu Ratnakumaran will be presenting 'Two-year toxicity outcomes from PACE-C: Stereotactic Body Radiotherapy (SBRT) versus moderate hypofractionated #radiotherapy (MHRT)' on Tuesday 20th September at 02:40pm PT in Room 22/23. #ProstateCancer

Dr David Thomson will be presenting 'Primary Results for the Phase III Trial of Toxicity Reduction using Proton Beam Therapy for #OropharyngealCancer (TORPEdO; CRUK/18/010)' in the plenary session on Monday 29th September at 1:48pm PT in the San Francisco Ballroom.